Immuron Ltd Files November 2025 6-K Report

TL;DR

Immuron Ltd filed a 6-K for Nov 2025, standard foreign private issuer update.

AI Summary

Immuron Limited filed a Form 6-K on November 21, 2025, reporting its activities for the month of November 2025. The filing indicates that the company is a foreign private issuer and is furnishing information to the SEC. No specific financial figures or operational updates were detailed in this particular filing.

Why It Matters

This filing serves as a routine update for investors and regulators, confirming Immuron's compliance with reporting requirements as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine administrative report and does not contain new material financial or operational information that would typically increase risk.

Key Players & Entities

• Immuron Limited (company) — Registrant
• United States Securities and Exchange Commission (company) — Recipient of filing

FAQ

Filing Documents

• ea0266714-6k_immuron.htm (6-K) — 16KB
• ea026671401ex99-1_immuron.htm (EX-99.1) — 120KB
• 0001213900-25-113596.txt ( ) — 137KB

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of November 2025 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on November 21, 2025 titled: 99.1 Change of Director’s Interest Notice A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Change of Director’s Interest Notice 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: November 21, 2025 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR